SMAD2 and breast carcinoma: At the same time, to clarify the correlation between miR-3613-3p and SMAD2/EZH2 in breast cancer, we tested tissue samples from cancer lesions and adjacent non-cancerous areas by using qRT-PCR and Western blotting.